Sumit Joshi

1.0k total citations
26 papers, 775 citations indexed

About

Sumit Joshi is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Molecular Biology. According to data from OpenAlex, Sumit Joshi has authored 26 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 11 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Sumit Joshi's work include Research on Leishmaniasis Studies (15 papers), Trypanosoma species research and implications (11 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Sumit Joshi is often cited by papers focused on Research on Leishmaniasis Studies (15 papers), Trypanosoma species research and implications (11 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Sumit Joshi collaborates with scholars based in India, Czechia and United States. Sumit Joshi's co-authors include Robert J. Currie, Cohn A. Ross, Anuradha Dube, Sunil Jalalpure, Malleswara Rao Peram, Prakash V. Diwan, Narendra Kumar Yadav, Vikash Kumar, Mohammad Imran Siddiqi and Shyam Sundar and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Frontiers in Immunology.

In The Last Decade

Sumit Joshi

26 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumit Joshi India 14 243 234 197 188 110 26 775
Laura Ravani Italy 20 180 0.7× 34 0.1× 155 0.8× 92 0.5× 210 1.9× 35 966
Shweta Saxena India 17 87 0.4× 65 0.3× 87 0.4× 178 0.9× 298 2.7× 57 1.1k
Dorothee Maria Gescher Germany 11 125 0.5× 33 0.1× 150 0.8× 133 0.7× 138 1.3× 24 763
William J. Reilly United Kingdom 16 15 0.1× 60 0.3× 92 0.5× 63 0.3× 40 0.4× 29 1.0k
Michael Ogundele United Kingdom 15 170 0.7× 56 0.2× 201 1.0× 132 0.7× 125 1.1× 57 903
José Ortíz Spain 18 49 0.2× 52 0.2× 57 0.3× 96 0.5× 276 2.5× 41 784
Heleen H. DeCory United States 16 325 1.3× 284 1.2× 62 0.3× 17 0.1× 102 0.9× 42 1.2k
Su Young Lee South Korea 11 95 0.4× 33 0.1× 41 0.2× 118 0.6× 87 0.8× 38 660
Alexandra Dinis Portugal 14 48 0.2× 111 0.5× 188 1.0× 31 0.2× 149 1.4× 34 692
Emily Walsh United States 13 93 0.4× 68 0.3× 163 0.8× 58 0.3× 232 2.1× 31 826

Countries citing papers authored by Sumit Joshi

Since Specialization
Citations

This map shows the geographic impact of Sumit Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumit Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumit Joshi more than expected).

Fields of papers citing papers by Sumit Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumit Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumit Joshi. The network helps show where Sumit Joshi may publish in the future.

Co-authorship network of co-authors of Sumit Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Sumit Joshi. A scholar is included among the top collaborators of Sumit Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumit Joshi. Sumit Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yadav, Narendra Kumar, et al.. (2022). Combined immunotherapeutic effect of Leishmania-derived recombinant aldolase and Ambisome against experimental visceral leishmaniasis. Journal of Microbiology Immunology and Infection. 56(1). 163–171. 3 indexed citations
2.
Joshi, Sumit, et al.. (2020). Status of IL‐4 and IL‐10 driven markers in experimental models of Visceral Leishmaniasis. Parasite Immunology. 43(1). e12783–e12783. 17 indexed citations
3.
Peram, Malleswara Rao, Sunil Jalalpure, & Sumit Joshi. (2019). A Simple RP-HPLC Method for the Determination of Curcumin in Commercial Turmeric Herbal Products. 33(1). 1 indexed citations
4.
Joshi, Sumit, Narendra Kumar Yadav, Vikash Kumar, et al.. (2019). Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani. Frontiers in Immunology. 10. 288–288. 16 indexed citations
5.
Saini, Sheetal, Anuradha Dube, Amogh A. Sahasrabuddhe, et al.. (2019). Comparison Between Immuno-Clinicopathological Features of Experimental and Human Visceral Leishmaniasis by Leishmania donovani. Acta Parasitologica. 65(1). 57–67. 5 indexed citations
6.
Yadav, Narendra Kumar, et al.. (2018). Immunotherapeutic potential of Leishmania ( Leishmania ) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis. Vaccine. 36(17). 2293–2299. 12 indexed citations
7.
Jaiswal, Anil K., K. Bhaskara Rao, Pragati Kushwaha, et al.. (2016). Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target. International Journal of Antimicrobial Agents. 48(6). 695–702. 10 indexed citations
8.
Joshi, Sumit, Narendra Kumar Yadav, Anil K. Jaiswal, et al.. (2016). Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani. Frontiers in Microbiology. 7. 312–312. 14 indexed citations
9.
Dube, Anuradha, et al.. (2016). Management of visceral leishmaniasis with therapeutic vaccines. Volume 6. 33–45. 5 indexed citations
10.
Singh, Pankaj Kumar, Jaya Gopal Meher, Sumit Joshi, et al.. (2016). Macrophage-targeted chitosan anchored PLGA nanoparticles bearing doxorubicin and amphotericin B against visceral leishmaniasis. RSC Advances. 6(75). 71705–71718. 41 indexed citations
13.
Joshi, Sumit, et al.. (2014). Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches. Frontiers in Immunology. 5. 380–380. 56 indexed citations
15.
Joshi, Sumit, et al.. (2013). Comparative immunogenicity and protective efficacy of different preparations of outer membrane proteins of Pasteurella multocida (B:2) in a mouse model.. Veterinarski arhiv. 83(6). 665–676. 4 indexed citations
17.
Das, Bidyadhar, Veena Tandon, Jitendra Kumar Saxena, Sumit Joshi, & Alok R. Singh. (2012). Purification and characterization of phosphoenolpyruvate carboxykinase fromRaillietina echinobothrida, a cestode parasite of the domestic fowl. Parasitology. 140(1). 136–146. 9 indexed citations
18.
Singh, Rashmi, et al.. (2012). Safety and immunogenicity of Brucella abortus strain RB51 vaccine in cross bred cattle calves in India.. PubMed. 50(3). 239–42. 10 indexed citations
19.
Joshi, Sumit, et al.. (2012). Prevalence of gastrointestinal helminth infections in rodents of Tarai region of Uttarakhand. Journal of Parasitic Diseases. 37(2). 181–184. 15 indexed citations
20.
Joshi, Sumit. (1996). G-PROTEINS IN GUINEA PIG AIRWAY SMOOTH MUSCLE: IDENTIFICATION AND FUNCTIONAL INVOLVEMENT. Pharmacological Research. 33(3). 195–202. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026